Write your message
Volume 7, Issue 3 (May & June - Volume 07 - Issue 03 2022)                   J Obstet Gynecol Cancer Res 2022, 7(3): 243-246 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Keikha F, Shooshtari M, Zamani N. Uterine Rupture in Second Trimester Due to Misoprostol Use: A Case Report and Literature Review. J Obstet Gynecol Cancer Res. 2022; 7 (3) :243-246
URL: http://jogcr.com/article-1-372-en.html
1- Department of Obstetrics and Gynecology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Obstetrics and Gynecology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran , dr.narges.zamani@gmail.com
Abstract:   (243 Views)

Intravaginal misoprostol is used worldwide with excellent results for second-trimester pregnancy termination. However, it has a rare but serious complication of uterine rupture, both in previously scarred and unscarred uteri. In this report, we present a case of this rare complication in an unscarred uterus during termination with misoprostol. Uterine rupture was found on laparotomy after the patient showed signs of shock during termination. A 2- to 3-cm laceration was detected in the uterine wall along with the left cornea. The placenta was attached to the uterus on the other side. We found an unusual pregnancy in the cornea and successfully repaired it. Although using misoprostol for termination is safe, a regimen protocol should be established. However, uterine structure and implantation safety should be confirmed before administrating misoprostol. This case highlights a difficult diagnosis of abnormal placentation, especially cornual ectopic pregnancy.

Full-Text [PDF 363 kb]   (32 Downloads) |   |   Full-Text (HTML)  (22 Views)  
Systematic Review: Case Report | Subject: Obstetrics and Gynecology
Received: 2021/07/22 | Accepted: 2021/09/22 | Published: 2022/01/12

References
1. Yuan Z, Shen K, Yang J, Cao D, Zhang Y, Zhou H, et al. Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study. Front Oncol. 2019;14(9): 237. [DOI:10.3389/fonc.2019.00237] [PMID] [PMCID]
2. Clement PB, Scully RE. Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol. 1990;21(4):363-81. [DOI:10.1016/0046-8177(90)90198-E]
3. Ulrich U, A, Denschlag D. Uterine Adenosarcoma. Oncol Res Treat. 2018; 41:693-6. ] [DOI:10.1159/000494067] [PMID]
4. Zaloudek CJ, Hendrickson MR, Soslow RA. Mesenchymal tumors of the uterus; in Kurman RJ, Hedrick Ellenson L, Ronnet BM (eds). Blaustein's Pathology of the Female Genital Tract, ed 6. New York, Springer,2011. [DOI:10.1007/978-1-4419-0489-8_10]
5. Hodgson A, Amemiya Y, Seth A, Djordjevic B, Parra-Herran C. High-grade Müllerian aden-osarcoma. Am J Surg Pathol. 2017;41(11):1513-22. [DOI:10.1097/PAS.0000000000000907] [PMID]
6. Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Uterine adenosarcoma: a review. Curr Oncol Rep. 2016; 18:68. [DOI:10.1007/s11912-016-0552-7] [PMID]
7. Fleming NA, Hopkins L, de Nanassy J, Senterman M, Black AY. Mullerian adenosarcoma of the cervix in a 10-year-old girl: case report and review of the literature. J Pediatr Adolesc Gynecol. 2009;22(4): e45-51. [DOI:10.1016/j.jpag.2008.06.001] [PMID]
8. Liu H, Shen Z, Wu D, Zhou Y. Uterine adenosarcoma with sarcomatous overgrowth: a case report of aggressive disease in a 16-year-old girl and a literature review. J Pediatr Adolesc Gynecol. 2018;31(4):426-31. [DOI:10.1016/j.jpag.2017.12.012] [PMID]
9. van Staalduinen B, Stahler A, Abied C, Shats R, Lakhi NA. Oncogenic potential and clinical implications of giant endometrial polyps: a case report and literature review. Case Rep Obstet Gynecol. 2018; 2018:1-6. [DOI:10.1155/2018/8753463] [PMID] [PMCID]
10. Wang JH, Zhao J, Lin J. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies. Minim Invasive Gynecol. 2010; 17:53-8. [DOI:10.1016/j.jmig.2009.10.012] [PMID]
11. Elfayomy AK, Soliman BS. Risk factors associated with the malignant changes of symptomatic and asymptomatic endometrial polyps in premenopausal women. Obstet Gynaecol India. 2015; 65:186-92. [DOI:10.1007/s13224-014-0576-6] [PMID] [PMCID]
12. Taga S, Sawada M, Nagai A, Yamamoto D, Hayase R. A Case of Adenosarcoma of the Uterus. Case Rep Obstet Gynecol. 2014;2014. [DOI:10.1155/2014/342187] [PMID] [PMCID]
13. Tanner EJ, Toussaint T, Leitao Jr MM, Hensley ML, Soslow RA, Gardner GJ, et al. Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecologic oncology. 2013;129(1):140-4. [DOI:10.1016/j.ygyno.2012.12.036] [PMID]
14. Shahidsales S, Farazestanian M, Sharifi‐Sistani N, Rasta S, Javadinia SA. TThe Uterine Adenosarcoma in a Young Woman Treated by TAH/BOS and Combined Adjuvant Therapy: A Case Report. Acta Medica Iranica. 2020:138-41. [DOI:10.18502/acta.v58i3.3779]
15. Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Uterine adenosarcoma: a review. Curr Oncol Rep. 2016;18(11):1-7. [DOI:10.1007/s11912-016-0552-7] [PMID]
16. Elfayomy AK, Soliman BS. Risk factors associated with the malignant changes of symptomatic and asymptomatic endometrial polyps in premenopausal women. Obstet Gynaecol India. 2015; 65:186-92. [DOI:10.1007/s13224-014-0576-6] [PMID] [PMCID]
17. Taga S, Sawada M, Nagai A, Yamamoto D, Hayase R. A Case of Adenosarcoma of the Uterus. Case Rep Obstet Gynecol. 2014;2014. [DOI:10.1155/2014/342187] [PMID] [PMCID]
18. Tanner EJ, Toussaint T, Leitao Jr MM, Hensley ML, Soslow RA, Gardner GJ, et al. Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecologic oncology. 2013;129(1):140-4. [DOI:10.1016/j.ygyno.2012.12.036] [PMID]
19. Shahidsales S, Farazestanian M, Sharifi‐Sistani N, Rasta S, Javadinia SA. TThe Uterine Adenosarcoma in a Young Woman Treated by TAH/BOS and Combined Adjuvant Therapy: A Case Report. Acta Medica Iranica. 2020:138-41. [DOI:10.18502/acta.v58i3.3779]
20. Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Uterine adenosarcoma: a review. Curr Oncol Rep. 2016;18(11):1-7. [DOI:10.1007/s11912-016-0552-7] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.